229 related articles for article (PubMed ID: 26875574)
1. [The guidelines for the diagnosis and management of multiple myeloma in China (2015 revision) : interpretation of the treatment of relapsing and refractory multiple myeloma].
Chen W
Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):93-4. PubMed ID: 26875574
[No Abstract] [Full Text] [Related]
2. [The guidelines for the diagnosis and management of multiple myeloma in China(2020 revision)].
; ;
Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):341-346. PubMed ID: 32370461
[TBL] [Abstract][Full Text] [Related]
3. [The guidelines for the diagnosis and management of multiple myeloma in China (2015 revision) : interpretation of diagnosis].
Du J; Hou J
Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):91-2. PubMed ID: 26875572
[No Abstract] [Full Text] [Related]
4. [The guidelines for the diagnosis and management of multiple myeloma in China (2015 revision) : interpretation of initial treatment].
Chen X
Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):92-3. PubMed ID: 26875573
[No Abstract] [Full Text] [Related]
5. [The guidelines for the diagnosis and management of multiple myeloma in China (2015 revision) : interpretation of response criteria].
Li J
Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):94-6. PubMed ID: 26875575
[No Abstract] [Full Text] [Related]
6. [Interpretation of minimal residual disease monitoring for response evaluation in "the guidelines for the diagnosis and management of multiple myeloma in China(2020 revision)"].
Chang YJ; Chen SN
Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):332-334. PubMed ID: 32370458
[TBL] [Abstract][Full Text] [Related]
7. [Interpretation of treatment of relapsed/refractory multiple myeloma patients in the guidelines for the diagnosis and management of multiple myeloma in China(2022 revision)].
Cai Z; Chen WM
Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):469-473. PubMed ID: 35488595
[TBL] [Abstract][Full Text] [Related]
8. [The guidelines for the diagnosis and management of multiple myeloma in China (2017 revision)].
; ;
Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):866-870. PubMed ID: 29136723
[TBL] [Abstract][Full Text] [Related]
9. [Best wishes to the guidelines for the diagnosis and management of multiple myeloma in China (2020 revision)].
Lu J
Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):329-331. PubMed ID: 32370457
[TBL] [Abstract][Full Text] [Related]
10. [Interpretation of diagnosis of multiple myeloma in the guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)].
Du J; Hou J
Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):463-465. PubMed ID: 35488593
[TBL] [Abstract][Full Text] [Related]
11. [Interpretation of treatment for newly diagnosed multiple myeloma patients in the guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)].
Liu JR; Li J
Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):465-469. PubMed ID: 35488594
[TBL] [Abstract][Full Text] [Related]
12. [A message to the guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)-a step further, a level higher].
Lu J
Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):460-462. PubMed ID: 35488592
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Moreau P; San Miguel J; Ludwig H; Schouten H; Mohty M; Dimopoulos M; Dreyling M;
Ann Oncol; 2013 Oct; 24 Suppl 6():vi133-7. PubMed ID: 23956208
[No Abstract] [Full Text] [Related]
14. IFM (Intergroupe francophone du myélome) recommendations for uniform interpretation of serum and urine protein electrophoresis in multiple myeloma diagnosis and follow-up.
Dejoie T; Lakomy D; Caillon H; Pegourié B; Decaux O
Ann Biol Clin (Paris); 2016 Aug; 74(4):429-41. PubMed ID: 27492696
[TBL] [Abstract][Full Text] [Related]
15. Problems monitoring response in multiple myeloma.
Collins CD
Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S119-26. PubMed ID: 16361127
[TBL] [Abstract][Full Text] [Related]
16. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
Shimizu K;
Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
[No Abstract] [Full Text] [Related]
17. Updates to the guidelines for the diagnosis and management of multiple myeloma.
Pratt G; Jenner M; Owen R; Snowden JA; Ashcroft J; Yong K; Feyler S; Morgan G; Cavenagh J; Cook G; Low E; Stern S; Behrens J; Davies F; Bird J
Br J Haematol; 2014 Oct; 167(1):131-3. PubMed ID: 24801672
[No Abstract] [Full Text] [Related]
18. [Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].
Issa N; Blondeau B; Dimicoli-Salazar S; Marit G; Morlat P; Camou F
Rev Med Interne; 2016 Aug; 37(8):567-9. PubMed ID: 26681106
[TBL] [Abstract][Full Text] [Related]
19. Management of multiple myeloma.
Richards JD; Singer CR; Tobias JS
Br J Hosp Med; 1987 May; 37(5):437, 440-2. PubMed ID: 2437986
[TBL] [Abstract][Full Text] [Related]
20. [To attach importance to standardized diagnosis and treatment, basic and translational study on multiple myeloma in our country].
Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):283-5. PubMed ID: 23668191
[No Abstract] [Full Text] [Related]
[Next] [New Search]
